Cerenome, Inc. (CNSY)
0.6601
-0.01
(-1.46%)
USD |
NASDAQ |
Nov 06, 16:00
0.6601
0.00 (0.00%)
After-Hours: 16:46
Cerenome Research and Development Expense (Annual) : 8.379M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 8.379M |
| December 31, 2024 | 10.58M |
| December 31, 2023 | 9.69M |
| December 31, 2022 | 9.698M |
| December 31, 2021 | 5.323M |
| December 31, 2020 | 2.70M |
| December 31, 2019 | 5.365M |
| December 31, 2018 | 5.523M |
| December 31, 2017 | 11.68M |
| December 31, 2016 | 16.20M |
| December 31, 2015 | 19.00M |
| December 31, 2014 | 15.10M |
| December 31, 2013 | 17.06M |
| December 31, 2012 | 13.63M |
| Date | Value |
|---|---|
| December 31, 2011 | 0.00 |
| December 31, 2010 | 9.687M |
| December 31, 2009 | 12.23M |
| December 31, 2008 | 17.37M |
| December 31, 2007 | 20.02M |
| December 31, 2006 | 21.98M |
| December 31, 2005 | 15.27M |
| December 31, 2004 | 11.01M |
| December 31, 2003 | 9.071M |
| December 31, 2002 | 5.605M |
| December 31, 2001 | 5.487M |
| December 31, 2000 | 2.565M |
| December 31, 1999 | 1.021M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Ernexa Therapeutics, Inc. | 4.156M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Anika Therapeutics, Inc. | 25.77M |
| Savara, Inc. | 81.40M |